Skip to main content

Acer Therapeutics

Newton, United States

Acer Therapeutics focuses on the acquisition, development, and commercialization of therapies for patients with serious rare diseases.

$1.0M raised
Jun 2023
Post-IPO Debt

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Acer Therapeutics

How much funding has Acer Therapeutics raised?
Acer Therapeutics has raised $1.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in June 2023.
Who are Acer Therapeutics's investors?
Acer Therapeutics's investors include Marathon Asset Management, TVM Capital Life Science, SWK Holdings.
Where is Acer Therapeutics headquartered?
Acer Therapeutics is headquartered in Newton, United States.
What does Acer Therapeutics do?
Acer Therapeutics focuses on the acquisition, development, and commercialization of therapies for patients with serious rare diseases.
What stage is Acer Therapeutics at?
Acer Therapeutics is at the Post-IPO Debt stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Acer Therapeutics — Funding & Investors." VCBacked, June 26, 2023, https://www.vcbacked.co/company/acer-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2023). Acer Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/acer-therapeutics
Wikipedia (cite web)
{{cite web |title=Acer Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/acer-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .